A Randomized Trial of Treatment Interruption before Optimized Antiretroviral Therapy for Persons with Drug‐Resistant HIV: 48‐Week Virologic Results of ACTG A5086
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.